These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 23263355)

  • 41. A pathological indicator for dysthyroid optic neuropathy: tritan color vision deficiency.
    Garip Kuebler A; Halfter K; Reznicek L; Klingenstein A; Priglinger S; Rudolph G; Hintschich C
    Graefes Arch Clin Exp Ophthalmol; 2021 Nov; 259(11):3421-3426. PubMed ID: 34159407
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Progression of visual field defects in leber hereditary optic neuropathy: experience of the LHON treatment trial.
    Newman NJ; Biousse V; Newman SA; Bhatti MT; Hamilton SR; Farris BK; Lesser RL; Turbin RE
    Am J Ophthalmol; 2006 Jun; 141(6):1061-1067. PubMed ID: 16765674
    [TBL] [Abstract][Full Text] [Related]  

  • 43. LHON needs to be genetically diagnosed and the idebenone effect quantified.
    Finsterer J; Aliyev R
    Rom J Ophthalmol; 2019; 63(3):306-307. PubMed ID: 31687636
    [No Abstract]   [Full Text] [Related]  

  • 44. Treatment of Leber hereditary optic neuropathy.
    Newman NJ
    Brain; 2011 Sep; 134(Pt 9):2447-50. PubMed ID: 21859767
    [No Abstract]   [Full Text] [Related]  

  • 45. [A study of clinical and genetic characteristics of a Leber hereditary optic neuropathy family with the heteroplasmic m.14484T>C mutation].
    Sun Y; Lei K; Xu ZL; Geng Y
    Zhonghua Yan Ke Za Zhi; 2018 Jul; 54(7):526-534. PubMed ID: 29996615
    [No Abstract]   [Full Text] [Related]  

  • 46. Current and Emerging Treatment Modalities for Leber's Hereditary Optic Neuropathy: A Review of the Literature.
    Theodorou-Kanakari A; Karampitianis S; Karageorgou V; Kampourelli E; Kapasakis E; Theodossiadis P; Chatziralli I
    Adv Ther; 2018 Oct; 35(10):1510-1518. PubMed ID: 30173326
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Leber's hereditary optic neuropathy (LHON/11778) with myoclonus: report of two cases.
    Carelli V; Valentino ML; Liguori R; Meletti S; Vetrugno R; Provini F; Mancardi GL; Bandini F; Baruzzi A; Montagna P
    J Neurol Neurosurg Psychiatry; 2001 Dec; 71(6):813-6. PubMed ID: 11723211
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Clinical and electrophysiology findings in Slovene patients with Leber hereditary optic neuropathy.
    Jarc-Vidmar M; Tajnik M; Brecelj J; Fakin A; Sustar M; Naji M; Stirn-Kranjc B; Glavač D; Hawlina M
    Doc Ophthalmol; 2015 Jun; 130(3):179-87. PubMed ID: 25690485
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Design, development, and characterization of an idebenone-loaded poly-ε-caprolactone intravitreal implant as a new therapeutic approach for LHON treatment.
    Varela-Fernández R; Lema-Gesto MI; González-Barcia M; Otero-Espinar FJ
    Eur J Pharm Biopharm; 2021 Nov; 168():195-207. PubMed ID: 34500025
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Letter to the Editor: Retinal morphological and functional response to Idebenone therapy in Leber hereditary optic neuropathy.
    Mercuţ MF; Tănasie CA; Nicolcescu AM; Ică OM; Mocanu CL; Dan AO
    Rom J Morphol Embryol; 2023; 64(3):443-444. PubMed ID: 37867363
    [No Abstract]   [Full Text] [Related]  

  • 51. Irreversible optic neuropathy in wernicke encephalopathy and leber hereditary optic neuropathy.
    Li JM; Rucker JC
    J Neuroophthalmol; 2010 Mar; 30(1):49-53. PubMed ID: 20182208
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Leber's hereditary optic neuropathy misdiagnosed as optic neuritis and Lyme disease in a patient with multiple sclerosis.
    Chang M
    BMJ Case Rep; 2018 Dec; 11(1):. PubMed ID: 30567205
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A Typical Case Presentation with Spontaneous Visual Recovery in Patient Diagnosed with Leber Hereditary Optic Neuropathy due to Rare Point Mutation in
    Liutkeviciene R; Sidaraite A; Kuliaviene L; Glebauskiene B; Jurkute N; Aluzaite-Baranauskiene L; Gelzinis A; Zemaitiene R
    Medicina (Kaunas); 2021 Feb; 57(3):. PubMed ID: 33652663
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Changes in Visual Function and Correlations with Inner Retinal Structure in Acute and Chronic Leber's Hereditary Optic Neuropathy Patients after Treatment with Idebenone.
    Pemp B; Mitsch C; Kircher K; Reitner A
    J Clin Med; 2021 Jan; 10(1):. PubMed ID: 33406801
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Safety of Intravitreal Gene Therapy for Treatment of Subjects with Leber Hereditary Optic Neuropathy due to Mutations in the Mitochondrial ND4 Gene: The REVEAL Study.
    Vignal-Clermont C; Girmens JF; Audo I; Said SM; Errera MH; Plaine L; O'Shaughnessy D; Taiel M; Sahel JA
    BioDrugs; 2021 Mar; 35(2):201-214. PubMed ID: 33566264
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Peripapillary microcirculation in Leber hereditary optic neuropathy.
    Kousal B; Kolarova H; Meliska M; Bydzovsky J; Diblik P; Kulhanek J; Votruba M; Honzik T; Liskova P
    Acta Ophthalmol; 2019 Feb; 97(1):e71-e76. PubMed ID: 30259673
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Genotypic and phenotypic characteristics of Korean children with childhood-onset Leber's hereditary optic neuropathy.
    Ahn YJ; Park Y; Shin SY; Chae H; Kim M; Park SH
    Graefes Arch Clin Exp Ophthalmol; 2020 Oct; 258(10):2283-2290. PubMed ID: 32506279
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Recurrent visual loss in Leber hereditary optic neuropathy: a case report].
    Momtchilova M; Pelosse B; Saliba M; Abdiche G; Doummar D; Laroche L; Billette De Villemeur T
    J Fr Ophtalmol; 2008 Apr; 31(4):409-15. PubMed ID: 18563041
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A phase 3, double-blind, placebo-controlled trial of idebenone in friedreich ataxia.
    Lynch DR; Perlman SL; Meier T
    Arch Neurol; 2010 Aug; 67(8):941-7. PubMed ID: 20697044
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Impairment of colour contrast sensitivity and neuroretinal dysfunction in patients with symptomatic HIV infection or AIDS.
    Geier SA; Kronawitter U; Bogner JR; Hammel G; Berninger T; Klauss V; Goebel FD
    Br J Ophthalmol; 1993 Nov; 77(11):716-20. PubMed ID: 8280686
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.